Financial Associated Press, December 16 - Hong Kong biomedical stocks rebounded, with Wuxi apptec up more than 8% and Yaoming biology up more than 5%.
Financial Associated Press, December 16 - Hong Kong biomedical stocks rebounded, with Wuxi apptec up more than 8% and Yaoming biology up more than 5%.
This text is a result of machine translation.
Related companies：
In-depth
Briefing Jun 28, 2022 09:44 AM
· Consumer Staples
The opening of tourism sector raised the limit of Lijiang shares
Briefing Jun 26, 2022 12:53 PM
· Consumer Staples
Guizhou reissued 155million yuan worth of cultural tourism consumption coupons on the 26th
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Apr 26, 2022 12:26 PM
Healthcare
CRO ClinChoice Raises USD 150 Mn in Series E Round
2015 is the inflection point for the development of China's innovative drug industry and CRO (clinical research organization). On July 22nd, 2015, after CDE (Center For Drug Evaluation) released the announcement on self-examination and verification of drug clinical trial data, the supervision of Chinese clinical trials moved towards standardization. The investment and financing of innovative drugs in China continued to increase, laying the foundation for the growth of CRO.
Jul 05, 2022 08:17 PM
Briefing Jun 13, 2022 09:44 AM
· Healthcare
Cro plate fell, and Wuxi apptec fell nearly 10%
Consumer Discretionary
Trip.com Q1 2021 Financial Results: Net Profit Increased by 80%
On May 19, China's travel service provider, Trip.com filed unaudited financial results for the first quarter ending March 31, 2021, which is the company's first financial report after the secondary listing on the Hong Kong Stock Exchange.
May 19, 2021 12:44 PM
Briefing May 31, 2022 03:08 PM
· Consumer Staples
Cross provincial travel "fuse" accurate to "county" Ctrip cross provincial travel product search volume increased by more than 60%
See more
Read next
Insight
In-depth